Start-Up Stadium Presentations Tuesday Afternoon

2:00 PM - 4:00 PM (EDT), Tuesday, June 6, 2023 ・ North Lobby
Start-Up Stadium is designed to provide start-up companies with the opportunity to engage key members of the investment community, venture philanthropy groups, strategic partners, and non-dilutive capital at the world’s largest biotechnology partnering event. During the 2023 BIO International Convention select finalists from around the world will share a quick pitch showcasing new technologies and therapeutic solutions to a panel of investor judges, followed by live feedback.

This year will also feature evaluation of the presentations from seed-stage company finalists (less than $1M raised) separate from emerging company finalists (more than $1M but less than $10M raised to date). with a winner identified for each category. Past prizes have included 'fast-track' admission review to incubator programs at the Illumina Accelerator and The Innovation Space, as well as complimentary, one-year memberships in the Biotechnology Innovation Organization with access to the cost-savings programs of BIO Business Solutions.
2:00 PM - 4:00 PM
The Native Cell Membrane Nanoparticle (NCMN) system is GPCR targeted, detergent-free protein…
North Lobby
48Hour Discovery (48HD) is a leading peptide-based platform accelerating discovery of novel…
North Lobby
MC Sciences is developing the Next Generation Therapeutics targeting mast cells. Based on the…
North Lobby
FELIQS, a Japanese startup company funded with a seed round of $2.5 million, develops a portfolio…
North Lobby
StemSight develops off-the-shelf regenerative cell therapies for corneal blindness using allogeneic…
North Lobby
Mirscience is a biotech company that develop RNA therapy for the treatment of wasting muscle…
North Lobby
T-E Meds, Inc. is a subsidiary company of T-E Pharma Holding which focuses on antibody-drug…
North Lobby
Anticipate Bioscience is built on 5 years of world class medicinal chemistry by a veteran oncology…
North Lobby
Zehna Therapeutics is developing non-bacteriocidal small molecule inhibitors of a specific gut…
North Lobby
Delymer - Novel polymer-based nanoparticles for targeted delivery and controlled release of gene…
North Lobby